131 related articles for article (PubMed ID: 37248422)
21. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.
Lipton SA
J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416
[TBL] [Abstract][Full Text] [Related]
22. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
23. Targeting organic cation transporters at the blood-brain barrier to treat ischemic stroke in rats.
Stanton JA; Williams EI; Betterton RD; Davis TP; Ronaldson PT
Exp Neurol; 2022 Nov; 357():114181. PubMed ID: 35905840
[TBL] [Abstract][Full Text] [Related]
24. Sulfonamide Moiety as "Molecular Chimera" in the Design of New Drugs.
Culletta G; Tutone M; Zappalà M; Almerico AM
Curr Med Chem; 2023; 30(2):128-163. PubMed ID: 35909290
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, ADME prediction and pharmacological evaluation of novel benzimidazole-1,2,3-triazole-sulfonamide hybrids as antimicrobial and antiproliferative agents.
Al-Blewi FF; Almehmadi MA; Aouad MR; Bardaweel SK; Sahu PK; Messali M; Rezki N; El Ashry ESH
Chem Cent J; 2018 Nov; 12(1):110. PubMed ID: 30387018
[TBL] [Abstract][Full Text] [Related]
26. Noscapine crosses the blood-brain barrier and inhibits glioblastoma growth.
Landen JW; Hau V; Wang M; Davis T; Ciliax B; Wainer BH; Van Meir EG; Glass JD; Joshi HC; Archer DR
Clin Cancer Res; 2004 Aug; 10(15):5187-201. PubMed ID: 15297423
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, structural characterization and in vitro evaluation of new 1,4-disubstituted-1,2,3-triazole derivatives against glioblastoma cells.
da Silva VD; de Faria BM; Colombo E; Ascari L; Freitas GPA; Flores LS; Cordeiro Y; Romão L; Buarque CD
Bioorg Chem; 2019 Mar; 83():87-97. PubMed ID: 30343205
[TBL] [Abstract][Full Text] [Related]
28. Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation.
Lipton SA
Curr Drug Targets; 2007 May; 8(5):621-32. PubMed ID: 17504105
[TBL] [Abstract][Full Text] [Related]
29. Prodrugs of Pyrazolo[3,4-d]pyrimidines: From Library Synthesis to Evaluation as Potential Anticancer Agents in an Orthotopic Glioblastoma Model.
Vignaroli G; Iovenitti G; Zamperini C; Coniglio F; Calandro P; Molinari A; Fallacara AL; Sartucci A; Calgani A; Colecchia D; Mancini A; Festuccia C; Dreassi E; Valoti M; Musumeci F; Chiariello M; Angelucci A; Botta M; Schenone S
J Med Chem; 2017 Jul; 60(14):6305-6320. PubMed ID: 28650650
[TBL] [Abstract][Full Text] [Related]
30. Dimeric small molecule agonists of EphA2 receptor inhibit glioblastoma cell growth.
Orahoske CM; Li Y; Petty A; Salem FM; Hanna J; Zhang W; Su B; Wang B
Bioorg Med Chem; 2020 Sep; 28(18):115656. PubMed ID: 32828423
[TBL] [Abstract][Full Text] [Related]
31. Modulation of blood-brain barrier dysfunction and neurological deficits during acute experimental allergic encephalomyelitis by the N-methyl-D-aspartate receptor antagonist memantine.
Paul C; Bolton C
J Pharmacol Exp Ther; 2002 Jul; 302(1):50-7. PubMed ID: 12065699
[TBL] [Abstract][Full Text] [Related]
32. Novel piperazine based benzamide derivatives as potential anti-glioblastoma agents inhibiting cell proliferation and cell cycle progression.
Lu Y; Feng Y; Li Z; Li J; Zhang H; Hu X; Jiang W; Shi T; Wang Z
Eur J Med Chem; 2022 Jan; 227():113908. PubMed ID: 34656900
[TBL] [Abstract][Full Text] [Related]
33. 3-Hydrazinoisatin-based benzenesulfonamides as novel carbonic anhydrase inhibitors endowed with anticancer activity: Synthesis, in vitro biological evaluation and in silico insights.
Abo-Ashour MF; Eldehna WM; Nocentini A; Bonardi A; Bua S; Ibrahim HS; Elaasser MM; Kryštof V; Jorda R; Gratteri P; Abou-Seri SM; Supuran CT
Eur J Med Chem; 2019 Dec; 184():111768. PubMed ID: 31629164
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the binding of 3-fluoromethyl-7-sulfonyl-1,2,3,4-tetrahydroisoquinolines with their isosteric sulfonamides to the active site of phenylethanolamine N-methyltransferase.
Grunewald GL; Seim MR; Regier RC; Martin JL; Gee CL; Drinkwater N; Criscione KR
J Med Chem; 2006 Sep; 49(18):5424-33. PubMed ID: 16942016
[TBL] [Abstract][Full Text] [Related]
35. Radiolabeled inhibitors as probes for imaging mutant IDH1 expression in gliomas: Synthesis and preliminary evaluation of labeled butyl-phenyl sulfonamide analogs.
Chitneni SK; Reitman ZJ; Gooden DM; Yan H; Zalutsky MR
Eur J Med Chem; 2016 Aug; 119():218-30. PubMed ID: 27163884
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of N-aryl-β-alanine derivatives as anticancer agents in triple-negative breast cancer and glioblastoma in vitro models.
Žukauskas M; Grybaitė B; Jonutė P; Vaickelionienė R; Gibieža P; Vaickelionis G; Dragūnaitė B; Anusevičius K; Mickevičius V; Petrikaitė V
Bioorg Chem; 2021 Oct; 115():105214. PubMed ID: 34426161
[TBL] [Abstract][Full Text] [Related]
37.
Lübtow MM; Oerter S; Quader S; Jeanclos E; Cubukova A; Krafft M; Haider MS; Schulte C; Meier L; Rist M; Sampetrean O; Kinoh H; Gohla A; Kataoka K; Appelt-Menzel A; Luxenhofer R
Mol Pharm; 2020 Jun; 17(6):1835-1847. PubMed ID: 32315193
[TBL] [Abstract][Full Text] [Related]
38. Novel 1,4-naphthoquinone-based sulfonamides: Synthesis, QSAR, anticancer and antimalarial studies.
Pingaew R; Prachayasittikul V; Worachartcheewan A; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Eur J Med Chem; 2015 Oct; 103():446-59. PubMed ID: 26397393
[TBL] [Abstract][Full Text] [Related]
39. Memantine transport by a proton-coupled organic cation antiporter in hCMEC/D3 cells, an in vitro human blood-brain barrier model.
Higuchi K; Kitamura A; Okura T; Deguchi Y
Drug Metab Pharmacokinet; 2015 Apr; 30(2):182-7. PubMed ID: 25857234
[TBL] [Abstract][Full Text] [Related]
40. Toxic effects of phytol and retinol on human glioblastoma cells are associated with modulation of cholesterol and fatty acid biosynthetic pathways.
Facchini G; Ignarro RS; Rodrigues-Silva E; Vieira AS; Lopes-Cendes I; Castilho RF; Rogerio F
J Neurooncol; 2018 Feb; 136(3):435-443. PubMed ID: 29159775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
